DrugPatentWatch Database Preview
Details for Patent: 8,158,645
Which drugs does patent 8,158,645 protect, and when does it expire?
Patent 8,158,645 protects HYCAMTIN and is included in one NDA.
This patent has eighteen patent family members in sixteen countries.
Summary for Patent: 8,158,645
| Title: | Compound, corresponding compositions, preparation and/or treatment methods |
| Abstract: | Disclosed is a novel crystalline form of topotecan monohydrochloride pentahydrate, which is a pentahydrate of 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indo- lizino[1,2-b]quinoline-3,14(4H,12H)dione monohydrochloride, corresponding pharmaceutical compositions, methods preparation and/or use thereof to treat anti-viral and/or cancer-related diseases. |
| Inventor(s): | Dell'Orco; Philip C. (King of Prussia, PA), Diederich; Ann Marie (King of Prussia, PA), Su; Qiaogong (King of Prussia, PA), Wood; Jeffery Lee (King of Prussia, PA) |
| Assignee: | GlaxoSmithKline LLC (Philadelphia, PA) |
| Application Number: | 12/770,898 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Process; Formulation; |
Drugs Protected by US Patent 8,158,645
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Pharms Corp | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981-001 | Oct 11, 2007 | RX | Yes | No | Start Trial | Start Trial | Y | Start Trial | ||||
| Novartis Pharms Corp | HYCAMTIN | topotecan hydrochloride | CAPSULE;ORAL | 020981-002 | Oct 11, 2007 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,158,645
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 046579 | Start Trial | |||
| Australia | 2004289318 | Start Trial | |||
| Brazil | PI0416366 | Start Trial | |||
| Canada | 2545876 | Start Trial | |||
| China | 1913897 | Start Trial | |||
| European Patent Office | 1689400 | Start Trial | |||
| Israel | 175369 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
